[1]JournalofMedicinalChemistry,2007,vol.50,p.2-5
[1]Patent:EP3511334,2019,A1.Locationinpatent:Paragraph0090-0091
[1]Patent:EP3511334,2019,A1.Locationinpatent:Paragraph0092-0093
68262-20-4 | 3-(3-Methoxyphenyl)-2-oxopropanoic acid | AA00FJ32 | MFCD09731950
104-67-6 | 2(3H)-Furanone, 5-heptyldihydro- | AA00HA6G | MFCD00005405
136911-45-0 | 1-Acetylazetidin-3-yl methanesulfonate | AA00HUNM | MFCD16620761
28108-99-8 | Phosphoric acid, 2-(1-methylethyl)phenyl diphenyl ester | AA00I57D | MFCD00870203
79026-03-2 | Fluorescent brightener er-iii | AA00ICWV | MFCD09751368
76300-15-7 | N-Methoxyadamantan-2-imine | AA00IKTU | MFCD27928467
2246751-85-7 | N-[2-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropanesulfonamide | AA00SOF2 | MFCD32206492
935528-07-7 | (4-Ethynylphenyl)methanamine hydrochloride | AA01AP29 | MFCD27922631
2060042-28-4 | methyl 2-oxo-3-(prop-2-en-1-yl)pyrrolidine-3-carboxylate | AA01BW30 | MFCD30476807
4424-87-7 | Benzo[1,2-c:4,5-c']diacridine-6,9,15,18(5H,14H)-tetrone | AA01DQ39 | MFCD00071846
